No Data
No Data
No Data
No Data
No Data
Fractyl Health, Inc.'s (NASDAQ:GUTS) Largest Shareholders Are Private Equity Firms With 52% Ownership, Individual Investors Own 30%
Yahoo FinanceMay 3 20:48
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
At DDG, Fractyl Health will present new clinical updates on its ongoing real-world registry study of Revita in patients with T2D in Germany At DDW, Fractyl Health will provide an oral presentation fro
GlobeNewswireApr 30 20:38
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Shares of Intel Corporation (NASDAQ:INTC) fell sharply in today's pre-market trading after th
BenzingaApr 3 17:36
Fractyl Health Names Adrian Kimber Chief Commercial Officer; Shares Down
Fractyl Health (GUTS) said Tuesday it appointed Adrian Kimber as chief commercial officer. Kimber was previously the global vice president and commercial head of neuromodulation at Biotronik, accordin
MT NewswiresApr 3 04:03
Fractyl Health Appoints Adrian Kimber Chief Comml Officer >GUTS
Fractyl Health Appoints Adrian Kimber Chief Comml Officer >GUTS
Dow JonesApr 2 20:00
Press Release: Fractyl Health Expands Leadership With Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
Fractyl Health, Inc. (Nasdaq: GUTS), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), today announced the appointment of Adrian Kimber as Chief Commercial Officer.
Dow JonesApr 2 20:00
No Data
No Data